Engelsk titel: MMR vaccination in 6–9 month olds
Läs online
Författare:
Sjöberg, Sara
;
Leach, Susannah
Email: susannah.leach@vgregion.se
Språk: Swe
Antal referenser: 20
Dokumenttyp:
Artikel
UI-nummer: 18030344
Sammanfattning
Vaccination against measles using the MMR vaccine is licensed from 9 months of age, but is used off-label from 6 months of age during or when travelling to areas with an ongoing measles outbreak. In this review of the published literature, studies on MMR vaccination in this age group are limited and small in size. Immunogenicity studies indicate that infants under 9 months respond with lower antibody titres but comparable T cell responses against measles. The safety profile of the vaccine does not appear to differ between infants vaccinated earlier or later. Vaccination from 6 months of age should be recommended if the risk of being infected with measles is considered greater than the risk of not attaining full vaccination protection.